BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 17315600)

  • 1. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
    Furuya M; Yonemitsu Y; Aoki I
    Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The great escape; the hallmarks of resistance to antiangiogenic therapy.
    van Beijnum JR; Nowak-Sliwinska P; Huijbers EJ; Thijssen VL; Griffioen AW
    Pharmacol Rev; 2015; 67(2):441-61. PubMed ID: 25769965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging tumor angiogenesis.
    Red-Horse K; Ferrara N
    J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of angiogenesis in cancers.
    Pang RW; Poon RT
    Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
    Jung YD; Ahmad SA; Liu W; Reinmuth N; Parikh A; Stoeltzing O; Fan F; Ellis LM
    Semin Cancer Biol; 2002 Apr; 12(2):105-12. PubMed ID: 12027582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines regulate tumor angiogenesis.
    Chakroborty D; Sarkar C; Basu B; Dasgupta PS; Basu S
    Cancer Res; 2009 May; 69(9):3727-30. PubMed ID: 19383906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor as an angiogenic factor.
    Nico B; Mangieri D; Benagiano V; Crivellato E; Ribatti D
    Microvasc Res; 2008 Mar; 75(2):135-41. PubMed ID: 17764704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Hall AP
    Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
    [No Abstract]   [Full Text] [Related]  

  • 14. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological angiogenesis and inflammation in tissues.
    Jeong JH; Ojha U; Lee YM
    Arch Pharm Res; 2021 Jan; 44(1):1-15. PubMed ID: 33230600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis: molecular pathways and therapeutic targets.
    Weis SM; Cheresh DA
    Nat Med; 2011 Nov; 17(11):1359-70. PubMed ID: 22064426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
    Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
    Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consice review: Contribution of cancer stem cells to neovascularization.
    Ping YF; Bian XW
    Stem Cells; 2011 Jun; 29(6):888-94. PubMed ID: 21557392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic and antiangiogenic chemokines.
    Bosisio D; Salvi V; Gagliostro V; Sozzani S
    Chem Immunol Allergy; 2014; 99():89-104. PubMed ID: 24217604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.